Galera Therapeutics Inc. (GRTX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
1 |
$499,979 |
| Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 02 Jan 2025 |
CHANG NANCY T |
Director , 10% |
30 Dec 2024 |
7,644,932 |
0.07 |
499,979 |
| 26 Feb 2024 |
SCHNEID YAIR |
10% |
08 Feb 2024 |
150,000 |
0.17 |
25,650 |
| 26 Feb 2024 |
SCHNEID YAIR |
10% |
07 Feb 2024 |
25,000 |
0.17 |
4,250 |
| 26 Feb 2024 |
SCHNEID YAIR |
10% |
07 Feb 2024 |
150,000 |
0.17 |
25,935 |
| 26 Feb 2024 |
SCHNEID YAIR |
10% |
06 Feb 2024 |
25,000 |
0.20 |
5,025 |
| 26 Feb 2024 |
SCHNEID YAIR |
10% |
05 Feb 2024 |
97,402 |
0.18 |
17,922 |
| 26 Feb 2024 |
SCHNEID YAIR |
10% |
30 Jan 2024 |
335,000 |
0.18 |
60,635 |
| 26 Feb 2024 |
SCHNEID YAIR |
10% |
29 Jan 2024 |
150,000 |
0.18 |
27,000 |
| 20 Mar 2023 |
BACHLEDA MARK |
Chief Commercial Officer |
16 Mar 2023 |
11,000 |
2.25 |
24,717 |
| 14 Mar 2023 |
SORENSEN MEL |
President and CEO |
10 Mar 2023 |
100,000 |
1.68 |
168,120 |
| 14 Mar 2023 |
DEGNAN CHRIS |
Chief Financial Officer |
13 Mar 2023 |
10,000 |
1.96 |
19,593 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock